Jheng-Yan Wu

2 papers in the library · 7 citations · publishing 2025-2026

Papers

Sort Most recent Most cited

Sustained effectiveness and safety of esketamine for major depressive disorder: a target trial simulation of real-world data.

Transl Psychiatry April 10, 2026 Ting-Hui Liu, Hong-Shiang Shen, Jheng-Yan Wu et al. 1 citation

Sustained effectiveness and safety of esketamine for major depressive disorder: a target trial simulation of real-world data.

DOI: 10.1038/s41398-026-04032-3 Full text

Risk of manic switch and suicidal outcomes in bipolar depression treated with esketamine: A one-year retrospective cohort study of 2126 patients.

European Neuropsychopharmacology August 6, 2025 Tingting Liu, Jheng-Yan Wu, Po-Yu Huang et al. 6 citations

OBJECTIVE To evaluate the safety of esketamine in bipolar depression, focusing on suicide-related outcomes and manic switch across timeframe and demographic subgroups. METHODS This retrospective cohort study was conducted in May 2025 using data from the TriNetX global collaborative network. Adults with bipolar depression treated with esketamine plus a mood stabilizer were propensity...

DOI: 10.1016/j.euroneuro.2025.07.006